HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Ogura Selected Research

Idiopathic Interstitial Pneumonias

1/2022Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.
11/2020Is unclassifiable idiopathic interstitial pneumonia a result of idiopathic pleuroparenchymal fibroelastosis?
4/2020Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan.
1/2020A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study.
11/2019Unique expression profiles of mucin proteins in interstitial pneumonia-associated lung adenocarcinomas.
1/2019Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial.
5/2018Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case.
1/2016Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
12/2015Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: The effect of the integrated clinico-radiological assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Ogura Research Topics

Disease

44Interstitial Lung Diseases (Interstitial Lung Disease)
10/2022 - 06/2010
37Idiopathic Pulmonary Fibrosis
06/2022 - 07/2011
22Neoplasms (Cancer)
01/2022 - 05/2003
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2006
17Disease Progression
06/2022 - 12/2006
14Lung Neoplasms (Lung Cancer)
07/2022 - 07/2010
12Bronchiectasis
08/2021 - 01/2005
11Pneumonia (Pneumonitis)
01/2022 - 01/2009
10Adenocarcinoma of Lung
07/2022 - 07/2010
9COVID-19
07/2022 - 01/2020
9Idiopathic Interstitial Pneumonias
01/2022 - 12/2015
9Fibrosis (Cirrhosis)
12/2020 - 06/2007
8Infections
07/2022 - 01/2005
8Dyspnea (Shortness of Breath)
11/2021 - 10/2011
8Adenocarcinoma
10/2020 - 07/2007
6Lung Diseases (Lung Disease)
11/2020 - 06/2006
6Brain Neoplasms (Brain Tumor)
04/2019 - 07/2012
5Body Weight (Weight, Body)
01/2022 - 01/2014
5Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 01/2016
5Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2021 - 01/2014
5Tuberculosis (Tuberculoses)
01/2021 - 01/2003
5Pulmonary Tuberculosis
12/2019 - 11/2008
5Neutropenia
01/2018 - 04/2008
4Polymyositis
10/2022 - 10/2008
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 07/2007
4Cysts
08/2021 - 11/2012
4Hypoxia (Hypoxemia)
12/2020 - 10/2009
4Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 01/2017
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 12/2006
3Respiratory Insufficiency (Respiratory Failure)
10/2022 - 01/2005
3Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2019
3Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
01/2022 - 12/2015
3Fever (Fevers)
12/2021 - 10/2009
3Diarrhea
03/2021 - 04/2019
3Anorexia
01/2021 - 09/2013
3Nausea
01/2021 - 02/2009
3Pneumothorax
11/2020 - 07/2008
3Esophageal Neoplasms (Esophageal Cancer)
11/2020 - 01/2017
3Asthma (Bronchial Asthma)
05/2020 - 05/2007
3Cough
03/2020 - 10/2011
3Hemorrhage
01/2020 - 05/2014
3Respiratory Tract Infections (Respiratory Tract Infection)
07/2009 - 01/2005
3Respiratory Tract Diseases (Respiratory Tract Disease)
02/2009 - 10/2004
2Pulmonary Alveolar Proteinosis
10/2022 - 05/2018
2Pericardial Effusion
07/2022 - 08/2020

Drug/Important Bio-Agent (IBA)

18pirfenidoneIBA
06/2022 - 07/2011
17nintedanibIBA
06/2022 - 05/2015
14Adrenal Cortex Hormones (Corticosteroids)IBA
07/2022 - 11/2012
8Pharmaceutical PreparationsIBA
01/2022 - 11/2008
7Immunoglobulins (Immunoglobulin)IBA
07/2021 - 04/2013
6Proteins (Proteins, Gene)FDA Link
10/2021 - 07/2014
6ErbB Receptors (EGF Receptor)IBA
01/2021 - 06/2010
6Carboplatin (JM8)FDA LinkGeneric
01/2020 - 04/2006
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
5Immunoglobulin G (IgG)IBA
01/2022 - 04/2013
5AntibodiesIBA
04/2021 - 01/2018
5Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2020 - 06/2007
5Bevacizumab (Avastin)FDA Link
11/2020 - 05/2014
5Cisplatin (Platino)FDA LinkGeneric
01/2018 - 07/2007
4AntigensIBA
01/2022 - 01/2005
4Biomarkers (Surrogate Marker)IBA
10/2021 - 07/2014
4Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 01/2005
4AfatinibIBA
01/2021 - 01/2016
4SteroidsIBA
11/2020 - 05/2007
4GemcitabineFDA Link
10/2020 - 07/2007
4Tyrosine Kinase InhibitorsIBA
01/2020 - 06/2010
4Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2017 - 10/2014
3Immunosuppressive Agents (Immunosuppressants)IBA
07/2022 - 10/2008
3atezolizumabIBA
01/2022 - 01/2020
3Oxygen (Dioxygen)IBA
12/2021 - 02/2015
3Prednisolone (Predate)FDA LinkGeneric
03/2021 - 05/2007
3Carbon MonoxideIBA
01/2021 - 06/2014
3osimertinibIBA
01/2021 - 04/2019
3Monoclonal AntibodiesIBA
01/2021 - 01/2020
3MethylprednisoloneFDA LinkGeneric
12/2020 - 10/2008
3Serum AlbuminIBA
12/2019 - 01/2014
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2019 - 04/2008
3Alanine Transaminase (SGPT)IBA
04/2019 - 04/2008
3C-Reactive ProteinIBA
11/2018 - 04/2013
3AnthracyclinesIBA
04/2016 - 02/2009
3Epirubicin (Ellence)FDA LinkGeneric
04/2016 - 04/2008
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2016 - 02/2009
3Paclitaxel (Taxol)FDA LinkGeneric
07/2015 - 04/2006
3Gefitinib (Iressa)FDA Link
07/2012 - 04/2006
3Voriconazole (Vfend)FDA LinkGeneric
05/2011 - 11/2008
2Glycine-tRNA LigaseIBA
10/2022 - 12/2016
2Rifampin (Rifampicin)FDA LinkGeneric
07/2022 - 12/2019
2Neutralizing AntibodiesIBA
02/2022 - 01/2021
2favipiravirIBA
12/2021 - 11/2020
2Midazolam (Versed)FDA LinkGeneric
11/2021 - 01/2021
2RamucirumabIBA
07/2021 - 01/2019

Therapy/Procedure

42Therapeutics
07/2022 - 01/2005
30Drug Therapy (Chemotherapy)
07/2022 - 01/2003
11Traction
08/2021 - 02/2008
6Combination Drug Therapy (Combination Chemotherapy)
07/2021 - 04/2006
3Artificial Respiration (Mechanical Ventilation)
01/2021 - 11/2020
2Extracorporeal Membrane Oxygenation
10/2022 - 01/2021
2Radiotherapy
07/2022 - 01/2017
2Immunotherapy
01/2022 - 11/2019
2Salvage Therapy
01/2021 - 12/2015